Peer-reviewedCC BYJournal of clinical medicine
Natriuretic Peptide Receptor-C (NPR3) in Pulmonary Hypertension Associated with Chronic Lung Disease: A PRISMA-ScR Scoping Review of Diagnostic, Prognostic, Mechanistic, and Therapeutic Evidence
- 1Laboratory of Human Metabolism and Non-Communicable Diseases, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaoundé P.O. Box 13033, Cameroon; (A.M.); (N.I.); (M.C.); (M.M.F.); (L.A.A.); (R.K.)
Related
- The CYB5R3–mARC1 Redox Axis in Metabolic Dysfunction-associated Steatotic Liver Disease: Mechanistic Basis and Therapeutic Prospects across the Steatosis–Cirrhosis–Hepatocellular Carcinoma Spectrum
- Novel variant and enteroendocrine hormone deficiency in a patient with proline and glutamate‐rich protein with a coiled coil domain 1 (PERCC1) associated enteropathy: New diagnostic and therapeutic insights
- The cGAS-STING pathway in metabolic dysfunction-associated steatotic liver disease: mechanistic insights and therapeutic opportunities
- Diagnostic Pitfall: Mixed Connective Tissue Disease-Associated Pulmonary Hypertension Presenting With Postpartum Right-Sided Heart Failure in a 21-Year-Old-Case Report.
- Entrectinib-associated perimyocarditis in ROS1-positive NSCLC: a diagnostic and therapeutic dilemma — a case report
BibTeX
@article{egom2026natriuretic,
title = {{Natriuretic Peptide Receptor-C (NPR3) in Pulmonary Hypertension Associated with Chronic Lung Disease: A PRISMA-ScR Scoping Review of Diagnostic, Prognostic, Mechanistic, and Therapeutic Evidence}},
author = {Emmanuel Eroume A Egom and Adamou Mfopa and Njimona Ibrahim and Mountchissi Célestin and Medou Mba Fabrice and Lum Abenwi Ambe and René Kamgang},
journal = {Journal of clinical medicine},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13666394},
note = {CC BY},
}
RIS
TY - JOUR
TI - Natriuretic Peptide Receptor-C (NPR3) in Pulmonary Hypertension Associated with Chronic Lung Disease: A PRISMA-ScR Scoping Review of Diagnostic, Prognostic, Mechanistic, and Therapeutic Evidence
AU - Emmanuel Eroume A Egom
AU - Adamou Mfopa
AU - Njimona Ibrahim
AU - Mountchissi Célestin
AU - Medou Mba Fabrice
AU - Lum Abenwi Ambe
AU - René Kamgang
PY - 2026
DA - 2026/09/24
JO - Journal of clinical medicine
UR - https://europepmc.org/article/PMC/PMC13666394
SN - 2077-0383
ER -